Mannanoligosaccharides

prebiotic

At a glance

Best for
no established human use; mostly studied as an animal feed additive
Typical dose
not established for humans
Time to effect
Uncertain
Main caution
human data are essentially absent; do not extrapolate livestock results to people
Evidence strength: Very limited in humans; most evidence is in animals and aquaculture

What is it

Mannanoligosaccharides (MOS) are short mannose-based carbohydrate chains, typically derived from the cell wall of yeast (Saccharomyces cerevisiae). They are used as a prebiotic-type feed additive, where they are thought to bind certain gut pathogens and support gut immunity. Almost all evidence comes from animal and aquaculture studies, with little human research.

Is it worth it for you?

Worth considering if…

  • you accept that human evidence is essentially absent and are experimenting cautiously

Probably skip if…

  • you want a benefit shown in human trials
  • you have a yeast allergy
  • you expect results comparable to studied prebiotics like inulin

Evidence at a glance

GoalEvidenceEffectBest fitTime
gut microbiota and pathogen bindingMixedUnknown in humansnot established in humansUncertain

Evidence for 1 use

AI-assisted evidence assessment — talk to your doctor before relying on any single supplement.

gut microbiota and pathogen binding

Mechanism only
Mixed

MOS can bind mannose-specific fimbriae on certain enteric bacteria and may modulate gut microbiota and immune markers, effects demonstrated largely in poultry, swine, and aquaculture. Human studies are sparse and do not establish a clinical benefit. Any effect in people is inferred from animal mechanisms rather than shown directly.

Effect size: Unknown in humans
Time to effect: Uncertain
Best fit: not established in humans

Bottom line: MOS shows pathogen-binding and microbiota effects in animals, but there is essentially no human evidence of benefit.

Evidence is mixed

Evidence is dominated by animal and aquaculture studies; controlled human trials are lacking.

How to take it

Typical dose
no validated human dose
Timing
as directed by the product
With food
with food
How long to try
short trial only

What to track

  • digestive comfort
  • bloating or gas
  • bowel regularity

Safety

Common side effects

gas, bloating (expected for fermentable carbohydrates)

Who should avoid it

  • people with yeast allergy or sensitivity

Pregnancy & breastfeeding

No human safety data in pregnancy; avoid supplemental use.

Choosing a product

Look for

  • states the source (e.g., yeast cell wall)
  • discloses amount per serving
  • intended for human use rather than animal feed

Be skeptical of

  • boosts immunity
  • treats infections
  • human benefits extrapolated from livestock studies

References by claim

gut microbiota and pathogen binding

  • Wang et al., 2018PubMed (2018) link
  • Gouveia et al., 2013PMC (2013) link

Track Mannanoligosaccharides with Pilora

Set up dose reminders, check interactions, and join the community in the Pilora iPhone app.

Coming to App Store
Evidence-based·Last reviewed May 30, 2026·Evidence current as of May 30, 2026·How we grade evidence

Disclaimer: These statements have not been evaluated by the FDA. This page is educational, not a substitute for personalized medical advice. Evidence grades are AI-assisted assessments — talk to your doctor before starting any new supplement, especially if you’re pregnant, breastfeeding, on medications, or managing a chronic condition.